Turner Investments’s Novartis NVS Stock Holding History

Turner Investments’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-893	Closed	-$63K	–	284
2016 Q3	$63K	Buy	893 +223	+33%	+$16.3K	0.02%	172
2016 Q2	$50K	Hold	670	–	–	0.02%	191
2016 Q1	$43K	Sell	670 -89,815	-99%	-$6.11M	0.01%	199
2015 Q4	$6.98M	Buy	90,485 +65,308	+259%	+$5.19M	1.44%	10
2015 Q3	$2.07M	Buy	25,177 +8,069	+47%	+$718K	0.42%	82
2015 Q2	$1.51M	Sell	17,108 -6,819	-28%	-$626K	0.28%	123
2015 Q1	$2.11M	Buy	23,927 +18,191	+317%	+$1.61M	0.38%	90
2014 Q4	$476K	Hold	5,736	–	–	0.06%	346
2014 Q3	$484K	Buy	+5,736	New	+$464K	0.03%	401

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Turner Investments's NVS Position: Q4 2016 in Review

Turner Investments sold out of Novartis (NVS) in Q4 2016, closing a stake of 893 shares — an estimated $63K sold.

Turner Investments first reported a position in NVS in Q3 2014 and held it in 9 quarters. The position peaked at $6.98M in Q4 2015. 904 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

Turner Investments reported no remaining Novartis position as of Q4 2016 after selling out during the quarter.
Turner Investments sold 893 Novartis shares in Q4 2016, an estimated $63K.
Turner Investments first reported a position in Novartis in Q3 2014 and held it in 9 quarters.
Turner Investments's Novartis position peaked at $6.98M in Q4 2015.
904 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on Turner Investments's 13F filing for Q4 2016, filed 8 Feb 2017.